tiprankstipranks
Phibro Animal Health (DE:PB8)
FRANKFURT:PB8
Germany Market

Phibro Animal Health (PB8) Blogger Opinions & Sentiment

1 Followers

Blogger Sentiment

Bullish: 60.00%
Sector Average
Bullish
DE:PB8 Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% Zacks
20% GuruFocus
20% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

PAHC SWOT Analysis: Strong Growth Potential Amidst Valuation Concerns Revealed in 10-K Filing
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

4 Stocks Trading Near 52-Week High With More Upside Potential
Zacks
4 Best PEG-Based Value Stocks to Buy for Market-Beating Returns
Zacks
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:PB8?
Seeking Alpha’s Myriam Alvarez has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:PB8?
    Currently there's no blogger sentiment for DE:PB8.
    What Is DE:PB8’s Blogger Sentiment?
    DE:PB8’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:PB8?
      The most recent blogger prediction for DE:PB8 was made by Zacks Equity Research, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          SENSSenseonics Holdings
          KURAKura Oncology